Vor Biopharma Inc. (VOR)
Nasdaq: VOR · Biological Products, (No Diagnostic Substances) · Boston, MA · filing with the SEC since 2020
Who runs Vor Biopharma Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Kress Jean-Paul
CEO and Chairman. First filing Jun 2025, latest Dec 9, 2025, 0 filings in all.
Officers reporting now
4
of 18 people with a filing in the last fifteen months
Directors reporting now
14
31 people on the record since 2021
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Sokolove Jeremy Brett | Chief Medical Officer | Apr 2026 | Nov 4, 2026 | none |
| Kress Jean-Paul | CEO and Chairman | Jun 2025 | Dec 9, 2025 | none |
| Mahatme Sandesh | CFO | Jul 2025 | Dec 9, 2025 | none |
| Zuraw Qing Che | Chief Development Officer | Jul 2025 | Dec 9, 2025 | none |
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kolchinsky Peter | director | Feb 2021 | Oct 5, 2026 | 5 · $14.5M |
| Ra Capital Healthcare Fund LP | director | Feb 2021 | Oct 5, 2026 | none |
| Ra Capital Management, L.P. | director | Feb 2021 | Oct 5, 2026 | 5 · $22.1M |
| Shah Rajeev M. | director | Feb 2021 | Oct 5, 2026 | 6 · $12.8M |
| Zaccardelli David | director | Jul 2026 | Jul 9, 2026 | none |
| Beckman Daniella | director | Feb 2021 | Jun 12, 2026 | none |
| Cumbo Alexander | director | Jul 2025 | Jun 12, 2026 | none |
| Detheux Michel | director | Jul 2025 | Jun 12, 2026 | none |
| Joustra Wouter | director | Dec 2025 | Jun 12, 2026 | none |
| Kalir Erez | director | Jan 2025 | Jun 12, 2026 | none |
| Levin Andrew David | director | Dec 2025 | Jun 12, 2026 | none |
| Namouni Fouad | director | May 2024 | Jun 12, 2026 | none |
| Ra Capital Nexus Fund, L.P. | director | May 2024 | Oct 22, 2025 | none |
| Reed Sarah Burgess | director | Sep 2025 | Sep 10, 2025 | none |
Owners of more than 10% of a classsales are open-market, Nov 4, 2025 to Nov 4, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Tcg Crossover Fund II, L.P. | 10% owner | Apr 2026 | Apr 1, 2026 | none |
| Tcg Crossover Fund III, L.P. | 10% owner | Apr 2026 | Apr 1, 2026 | none |
| Tcg Crossover Gp II, LLC | 10% owner | Apr 2026 | Apr 1, 2026 | none |
| Tcg Crossover Gp III, LLC | 10% owner | Apr 2026 | Apr 1, 2026 | none |
| Hoffman Reid | 10% owner | Dec 2024 | Oct 21, 2025 | none |
| Reprogrammed Interchange LLC | 10% owner | Dec 2024 | Oct 21, 2025 | none |
Earlier names on the record20, newest filing first
Lubner David Charles · director · last filing May 2025Lundberg Sven Ante · director · last filing May 2025Patterson Matthew R · director · last filing May 2025Resnick Joshua · director · last filing May 2025Ang Robert · officer · last filing May 2025Chakraborty Tirtha · officer · last filing May 2025Choi Han Wook · officer · last filing May 2025Attar Eyal C. · officer · last filing Feb 2025Quinlan Amy · officer · last filing Nov 2024Jorgensen Nathan D. · officer · last filing May 2024Parmar Kush · director · last filing Jun 2022Slapak Christopher · officer · last filing Feb 20225am Opportunities I (Gp), LLC · 10% owner · last filing Nov 20215am Opportunities I, L.P. · 10% owner · last filing Nov 20215am Partners Vi, LLC · 10% owner · last filing Nov 20215am Ventures Vi, L.P. · 10% owner · last filing Nov 2021Schwab Andrew J. · 10% owner · last filing Nov 2021Alexandria Venture Investments, LLC · 10% owner · last filing Feb 2021Kassim Sadik · officer · last filing Feb 2021Puretech Health LLC · 10% owner · last filing Feb 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.